本月创新药板块催化频至！港股创新药ETF（159567）现涨3.69%，实时换手率突破47%排名同指数第一

Group 1 - The Hong Kong stock market saw a significant rise on June 9, with the innovative drug sector leading the gains, highlighted by companies like Genscript Biotech rising over 16% and Innovent Biologics increasing over 13% [1] - The Hong Kong innovative drug ETF (159567) recorded an average daily trading volume exceeding 1.2 billion yuan over the past five trading days, indicating high market enthusiasm [1] - Upcoming events such as the European League Against Rheumatism (EULAR) conference and the American Diabetes Association (ADA) scientific meeting are expected to provide positive catalysts for the innovative drug sector [1] Group 2 - The innovative drug ETF (159567) tracks the National Index of Hong Kong Innovative Drugs, with 90% of its weight in innovative drug companies, making it the highest among all pharmaceutical-themed indices [2] - The innovative drug ETF (159992) tracks a broader innovative drug index, including leading companies in the innovative drug industry chain, benefiting from trends like AI-enabled drug development and the international expansion of domestic innovative drugs [2] - Recent key events, such as the partnership between 3SBio and Pfizer for a PD-1/VEGF dual antibody deal worth $1.25 billion, highlight the increasing competitiveness of Chinese innovative drug companies on a global scale [2]